Castle Biosciences Inc (CSTL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CSTL? Forum Prognose

Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.05% 86.19	87.99	85.78	87.00	72.97
Cost Of Revenue	7.59% 17.63	16.38	15.61	14.52	13.89
Gross Profit	4.25% 68.56	71.61	70.17	72.48	59.08
Operating Expenses	26.85% 72.81	99.53	65.09	67.47	64.55
Interest Income/Expense	12.50% 0.009	0.008	0.192	0.216	0.014
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	21.98% 90.44	115.92	80.70	81.99	78.44
Operating Income/Loss	84.78% -4.251	-27.93	5.079	5.012	-5.471
Income/Loss From Continuing Operations Before Tax	433.44% 86.19	-25.85	85.78	8.92	-2.534
Income Tax Expense/Benefit, Deferred	506.10% -4.667	-0.77	5.25	-1.542	-
Income Tax Expense/Benefit	1,003% -4.666	-0.423	6.013	-1.034	0.045
Income/Loss From Continuing Operations After Tax	117.50% 4.523	-25.85	2.269	8.92	-2.534
Net Income/Loss	117.50% 4.523	-25.85	2.269	8.92	-2.534
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.07% 28.91	28.61	27.84	27.65	27.48
Diluted Average Shares	3.27% 29.55	28.61	29.40	28.74	27.48
Basic Earnings Per Share	117.78% 0.16	-0.90	0.08	0.32	-0.09
Diluted Earnings Per Share	116.67% 0.15	-0.90	0.08	0.31	-0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

WAT

$299.69

3.32%

DGX

$180.11

0.33%

NTRA

$166.56

0.58%

$275.23

0.51%

MTD

$1,287.79

1.51%

IQV

$184.08

0.29%